Cargando…
Annual reports in medicinal chemistry. Volume 29.
This serial continues to combine regular updates of significant research in medicinal chemistry with emerging research in biological science destined to impact the discovery and development of new medicinal agents.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego, Calif. ; London :
Academic Press,
1994.
|
| Colección: | Annual reports in medicinal chemistry ;
v. 29 |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; Annual Reports in Medicinal Chemistry, Volume 29; Copyright Page; Contents; Contributors; Preface; SECTION I: CNS AGENTS; Chapter 1. Toward Third Generation Antidepressants; Chapter 2. Neuronal Cell Death and Strategies for Neuroprotection; Chapter 3. Recent Advances in the Design and Characterization of Muscarinic Agonists and Antagonists; Chapter 4. Animal Engineering in Neurobiology; Chapter 5. Recent Advances in Dopamine D3 and D4 Receptor Ligands and Pharmacology; Chapter 6. Recent Progress in Excitatory Amino Acid Resesarch; SECTION II: CARDIOVASCULAR AND PULMONARY AGENTS
- Chapter 7. Small Molecule Endothelin Receptor AntagonistsChapter 8. Emerging Opportunities in the Treatment of Asthma and Allergy; Chapter 9 . The Enzymology and Manipulation of Nitric Oxide Synthase; Chapter 10. Thrombolytic Agents; Chapter 11. Antithrombotic and Anti-Inflammatory Agents of the Protein C Anticoagulant Pathway; SECTION III: CHEMOTHERAPEUTIC AGENTS; Chapter 12. Antibacterial Agents; Chapter 13. Advances in the Development of HIV Reverse Transcriptase Inhibitors; Chapter 14. HIV Protease Inhibitors; Chapter 15. Antiviral Agents
- Chapter 16. Problems and Progress in Opportunistic InfectionsChapter 17. Ras Oncogene Directed Approaches in Cancer Chemotherapy; SECTION IV: IMMUNOLOGY, ENDOCRINOLOGY,AND METABOLIC DISEASES; Chapter 18. Non-lmmunophilin-Related Immunosuppressants; Chapter 19. Isozyme-Selective Phosphodiesterase Inhibitors as Antiasthmatic Agents; Chapter 20. Human Leukocyte Elastase Inhibitors; Chapter 21. Interleukin-1 as a Therapeutic Target; Chapter 22. Cell Adhesion and Carbohydrates; Chapter 23. Therapeutic Control of Androgen Action; SECTION V: TOPICS AN BIOLOGY
- Chapter 24. Transcription Factor NF-KB: An Emerging Regulator of InflammationChapter 25. Translational Control of Gene Expression; Chapter 26. Protein Kinases and Phosphatases: Structural Biology and Synthetic Inhibitors; Chapter 27. Transgenic and Gene Targeting Technology in Drug Discovery; Chapter 28. Emerging Therapies in Osteoporosis; SECTION VI: TOPICS IN DRUG DESIGN AND DESCOVERY; Chapter 29. Adenylate Cyclase Subtypes as Molecular Drug Targets; Chapter 30. Recent Advances in Antisense Technology; Chapter 31. In Vitro Approaches for the Prediction of Human Drug Metabolism
- Chapter 32. Humanized Monoclonal AntibodiesChapter 33. Ethnobotany as a Source for New Drugs; SECTION VII: TRENDS AND PERSPECTIVES; Chapter 34. To Market, To Market
- 1993; Compound Name, Code Number and Subject Index, Volume 29; Cumulative Chapter Titles Keyword Index, Volumes 1-29; Cumulative Nce Introduction Index, 1983-1993; Cumulative Nce Introduction Index, 1983-1993, by Indication